Sigma Healthcare Limited
SIG
株式のランク
#1045
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
株価
$1.95
時価総額
$22.39B
変化（1日）
-0.18%
変化（1年）
-1.35%
国
AU
取引 Sigma Healthcare Limited (SIG)
カテゴリー
Healthcare
Sigma Healthcare Limited（SIG）の収益
Jun 2026 時点の収益 TTM: $7.64B
Sigma Healthcare Limited の最新の財務報告によると、現在の収益 (TTM) は $7.64B です。2024 年には $2.18B の収益があり、これは 2023 年の $2.58B と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Sigma Healthcare Limited の収益履歴（2001 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $7.64B | 150.36% |
| 2025 | $3.05B | 39.95% |
| 2024 | $2.18B | -15.49% |
| 2023 | $2.58B | 5.96% |
| 2022 | $2.44B | -5.99% |
| 2021 | $2.59B | 19.30% |
| 2020 | $2.17B | -24.90% |
| 2019 | $2.89B | -12.38% |
| 2018 | $3.30B | -0.28% |
| 2017 | $3.31B | 35.12% |
| 2016 | $2.45B | 0.35% |
| 2015 | $2.44B | -6.25% |
| 2014 | $2.60B | -15.90% |
| 2013 | $3.10B | 1.20% |
| 2012 | $3.06B | 4.45% |
| 2011 | $2.93B | 27.32% |
| 2010 | $2.30B | 4.91% |
| 2009 | $2.19B | -18.21% |
| 2008 | $2.68B | 26.67% |
| 2007 | $2.12B | 27.55% |
| 2006 | $1.66B | 531.67% |
| 2004 | $262.65M | 32.71% |
| 2003 | $197.92M | 42.01% |
| 2002 | $139.37M | 98.14% |
| 2001 | $70.34M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $410.98B | 5,278.14% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,227.10% |
US
|
|
| - | - |
US
|
|
| $13.60B | 78.00% |
US
|
